Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationHematopoietic Stem CellsTransplantation ConditioningHematologic NeoplasmsStem Cell TransplantationAntigens, CD34MelphalanStem CellsGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisGraft vs Host DiseaseBlood Component RemovalMultiple MyelomaCyclophosphamideTreatment OutcomeBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsGraft SurvivalBusulfanMyeloablative AgonistsLymphoma, Non-HodgkinRecurrenceHematopoiesisRemission InductionEtoposideTissue DonorsThiotepaAntineoplastic Agents, AlkylatingRetrospective StudiesCytophagocytosisCarmustineSalvage TherapyCord Blood Stem Cell TransplantationTransplantation ChimeraWhole-Body IrradiationHistocompatibilityIfosfamideCytomegalovirus InfectionsAmyloidosisTime FactorsNeoplasmsVincristineSurvival RateDisease-Free SurvivalHodgkin DiseaseCytarabineOpportunistic InfectionsSurvival AnalysisHistocompatibility TestingLeukemiaEmbryonic Stem CellsImmunosuppressive AgentsInfectionImmunocompromised HostFatal OutcomeAdult Stem CellsHematologic DiseasesLeukemia, Myeloid, AcuteLymphoma, T-CellFollow-Up StudiesDoxorubicinPlatelet CountVidarabineProspective StudiesCell DifferentiationPOEMS SyndromeTransplantation, IsogeneicBlood Cell CountPrednisoneGraft vs Leukemia EffectStem Cell NicheMesenchymal Stem Cell TransplantationCarboplatinDexamethasoneAntineoplastic AgentsTransplantationRecombinant ProteinsBone Marrow PurgingBlood CellsBone Marrow CellsLymphomaPluripotent Stem CellsFlow CytometryBone MarrowMyelodysplastic SyndromesAnemia, AplasticCell SeparationHepatic Veno-Occlusive DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFeasibility StudiesCell LineageCells, CulturedImmunophenotypingMycosesStem Cell Factor